Decreased CD27 on B lymphocytes in patients with primary hepatocellular carcinoma

19Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

OBJECTIVES: Hepatitis B virus (HBV) replicates in the liver and can lead to hepatocellular carcinoma (HCC). The B lymphocytes may provide a means for HBV to persist although the mechanism remains unknown. This study aimed to characterize B lymphocyte subset phenotypes and measure levels of B lymphocyte-related cytokines in HCC patients. Methods: The study population included 38 HCC patients and 30 healthy control subjects. Phenotyping of B lymphocytes was performed by flow cytometry. Serum cytokine levels were measured using a cytometric bead array immunoassay. Results: The ratio of naïve (CD29+CD27-) to memory (CD19+CD27+) B lymphocytes was significantly higher in HCC patients compared with healthy controls. The percentage of memory B lymphocytes decreased with the progression of HCC. Levels of interleukin (IL)-6 and IL-10 were significantly increased in HCC patients compared with healthy controls. Conclusion: The depletion of memory B lymphocytes may contribute to unresponsiveness to HBV or to HCC. This humoral defect might be related to raised production of IL-6 and IL-10. © 2012 Field House Publishing LLP.

Cite

CITATION STYLE

APA

Wang, X. D., Wang, L., Ji, F. J., Zhu, J. M., Ayana, D. A., & Fang, X. D. (2012). Decreased CD27 on B lymphocytes in patients with primary hepatocellular carcinoma. Journal of International Medical Research, 40(1), 307–316. https://doi.org/10.1177/147323001204000131

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free